vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and DENNY'S Corp (DENN). Click either name above to swap in a different company.
DENNY'S Corp is the larger business by last-quarter revenue ($113.2M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). DENNY'S Corp runs the higher net margin — 0.6% vs -70.9%, a 71.5% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 1.3%). DENNY'S Corp produced more free cash flow last quarter ($16.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -0.9%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Denny's is an American table service diner-style restaurant chain. It operates over 1,400 restaurants in the United States, Canada, México, Puerto Rico, and several other international locations.
CTKB vs DENN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $113.2M |
| Net Profit | $-44.1M | $632.0K |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 9.2% |
| Net Margin | -70.9% | 0.6% |
| Revenue YoY | 8.1% | 1.3% |
| Net Profit YoY | -557.1% | -90.3% |
| EPS (diluted) | — | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | — | ||
| Q3 25 | $52.3M | $113.2M | ||
| Q2 25 | $45.6M | $117.7M | ||
| Q1 25 | $41.5M | $111.6M | ||
| Q4 24 | $57.5M | $114.7M | ||
| Q3 24 | $51.5M | $111.8M | ||
| Q2 24 | $46.6M | $115.9M | ||
| Q1 24 | $44.9M | $110.0M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $632.0K | ||
| Q2 25 | $-5.6M | $2.5M | ||
| Q1 25 | $-11.4M | $326.0K | ||
| Q4 24 | $9.6M | $6.8M | ||
| Q3 24 | $941.0K | $6.5M | ||
| Q2 24 | $-10.4M | $3.6M | ||
| Q1 24 | $-6.2M | $4.7M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | 9.2% | ||
| Q2 25 | -23.3% | 7.3% | ||
| Q1 25 | -36.1% | 4.7% | ||
| Q4 24 | 5.2% | 12.6% | ||
| Q3 24 | -8.2% | 10.5% | ||
| Q2 24 | -18.3% | 7.9% | ||
| Q1 24 | -23.9% | 9.1% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 0.6% | ||
| Q2 25 | -12.2% | 2.1% | ||
| Q1 25 | -27.5% | 0.3% | ||
| Q4 24 | 16.8% | 5.9% | ||
| Q3 24 | 1.8% | 5.8% | ||
| Q2 24 | -22.4% | 3.1% | ||
| Q1 24 | -13.8% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.05 | ||
| Q1 25 | — | $0.01 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | — | $0.12 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-32.7M |
| Total Assets | $461.5M | $502.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | $1.1M | ||
| Q4 24 | $98.7M | $100.0K | ||
| Q3 24 | $162.3M | $2.9M | ||
| Q2 24 | $177.9M | $2.8M | ||
| Q1 24 | $168.8M | $2.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $270.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | — | ||
| Q3 25 | $378.6M | $-32.7M | ||
| Q2 25 | $377.6M | $-34.6M | ||
| Q1 25 | $379.6M | $-36.4M | ||
| Q4 24 | $395.7M | $-34.0M | ||
| Q3 24 | $385.5M | $-54.5M | ||
| Q2 24 | $389.1M | $-53.2M | ||
| Q1 24 | $392.6M | $-55.7M |
| Q4 25 | $461.5M | — | ||
| Q3 25 | $494.9M | $502.9M | ||
| Q2 25 | $493.3M | $491.1M | ||
| Q1 25 | $482.6M | $488.1M | ||
| Q4 24 | $499.5M | $496.3M | ||
| Q3 24 | $491.2M | $461.6M | ||
| Q2 24 | $483.7M | $459.9M | ||
| Q1 24 | $492.1M | $460.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $16.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $16.0M |
| FCF MarginFCF / Revenue | -2.9% | 14.1% |
| Capex IntensityCapex / Revenue | 1.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 25.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | — | ||
| Q3 25 | $-3.9M | $16.0M | ||
| Q2 25 | $108.0K | $9.4M | ||
| Q1 25 | $-125.0K | $5.0M | ||
| Q4 24 | $2.0M | $8.5M | ||
| Q3 24 | $13.2M | $6.6M | ||
| Q2 24 | $6.2M | $14.2M | ||
| Q1 24 | $4.0M | $215.0K |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | $16.0M | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | 14.1% | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.28× | ||
| Q2 25 | — | 3.79× | ||
| Q1 25 | — | 15.38× | ||
| Q4 24 | 0.21× | 1.26× | ||
| Q3 24 | 14.05× | 1.01× | ||
| Q2 24 | — | 3.97× | ||
| Q1 24 | — | 0.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
